Seikagaku Corporation (4548) widened its net loss forecast for the year ending March 2027 to ¥2.7 billion from ¥1.8 billion and its operating loss forecast to ¥2.9 billion from ¥2.05 billion, citing higher R&D spending to prepare for the resubmission of SI-6603.
The revised forecast keeps sales unchanged at ¥37.1 billion. Ordinary profit is now projected at a loss of ¥650 million, versus a ¥200 million profit previously, and the net loss per share at ¥49.43, versus ¥32.96. The company said its dividend forecast is unchanged. For the year ended March 2026, it posted net profit of ¥1.47 billion.
For the April-September first half, sales rose 1.7% to ¥18.22 billion. The operating loss widened to ¥1.42 billion from ¥557 million a year earlier on higher manufacturing costs and R&D expenses. Ordinary profit rose 13.4% to ¥602 million, helped by sales of investment securities. The company swung to a net loss of ¥1.22 billion from a ¥229 million profit, as tax expenses rose following the reversal of deferred tax assets.
Domestic pharmaceutical sales rose 7.1% to ¥6.25 billion, while overseas pharmaceutical sales fell 35.8% to ¥2.83 billion, mainly on lower shipments of Gel-One to the U.S., attributed chiefly to shipment timing, and of Artz to China, where shipments were temporarily halted for procedures related to a change in materials. The LAL business grew 17.3% to ¥6.78 billion.
The interim dividend was ¥10 per share, with a full-year forecast of ¥20, compared with ¥30 for the previous year.
Next steps: The company plans to file its half-year securities report on Nov. 12, 2026, and post supplementary materials on its website the same day. Dividend payments are scheduled to begin Dec. 2, 2026. Artz shipments to China are scheduled to resume from the third quarter.
| I-ne | |
| Tender offer price | ¥2,248 per share |
| Kadoya Seiyu | |
| Tender offer price | ¥2,655 per share |
| TKP Corporation | |
| Effective date | March 1, 2027 (scheduled) |
| M3, Inc. | |
| Tender offer price | ¥1,619 per share |
| Digital Hearts Holdings | |
| Consolidation ratio | 2,975,211 shares into 1 share |
| Shoei Corporation | |
| Shares transferred | 1.8 million shares |
| TOSE Co., Ltd. | |
| Effective date (scheduled) | Jan. 4, 2027 |
| NSK Ltd. | |
| Share transfer ratio (NSK:NTN) | 1:0.353 |
| M&A / TOB | 20 |
| Guidance | 7 |
| Buybacks | 11 |
| Dividends | 4 |
| Capital | 12 |
| Earnings | 16 |
| People | 3 |
Summaries of public disclosures by Japanese listed companies. Not investment advice; accuracy not guaranteed. Figures and dates in the TDnet originals prevail.
本站內容為日本上市公司公開開示之摘要整理,非投資建議,亦不保證正確。數字與日程以 TDnet 原文為準。
本サイトは日本の上場企業の適時開示を要約したものであり、投資助言ではありません。正確性は保証しません。数値・日程は TDnet の原文が優先します。